-
[SEQENS CDMO] The growth of the generic drug marketplace : A win-win for the industry and patients. Discover the analyse of Laurent Alexandre, Director, Proprietary APIs, at Seqens CDMO on our blog
https://lnkd.in/dYvM5NH
#SEQENS#CDMO#APIspic.twitter.com/OjbBYl1r0d
-
At Custom Pharma we are licensed for the manufacture of veterinary medication, we're working on some exciting projects so make sure you follow us and you can click the link below to sign up to our mailing list! http://bit.ly/37YFs2Q
#pharma#pharmaceuticals#cdmo pic.twitter.com/XWoB9DcK9w
-
More expansion news from LSNE!!
#growth#CDMO https://twitter.com/contractpharma/status/1225086056963461121 … -
#coronavirus#vaccines#C1technology could produce much larger volumes at a reduced cost
we are the #worldwide leader#CDMO using#C1. Breaking news:@FoxBizAlert@DyadicInchttps://www.youtube.com/watch?v=jQj_oF-y2pQ&feature=youtu.be … -
Meet the Kemwell team at Annual Biologics Manufacturing Asia 2020 Singapore. To know more details contact the Kemwell team. . . Girish Joshi, PhD, Jaby Jacob, Sanjay Lodha, Rachit Gunderia .
#kemwell#CDMO#CMO#biologics#singapore#manufacturingpic.twitter.com/Jk4VMLrEre
-
#Catalent to buy cell and#genetherapy#CDMO#MaSTherCell for $315mhttps://hubs.ly/H0mTf940 -
Catalent laying out $315M to snatch another gene therapy
#CDMO https://www.fiercepharma.com/manufacturing/catalent-laying-out-315m-to-snatch-another-gene-therapy-cdmo …https://lnkd.in/ejeJyVz -
Nice, short summary of 3 keys in selecting a CDMO.
#Pharma#Biotech#CellTherapy#CDMO https://lnkd.in/e4YPz8u -
Kemwell’s team of experienced scientists strive to develop a robust, efficient, scaled up manufacturing process to deliver consistent product quality. . .
#kemwell#CDMO#CMO#biologicspic.twitter.com/Wv9merM6Rk
-
EXPERTISE CHOSEN TO DELIVER 100% DATA DRIVEN - The strength of Quay is our people. We invest in the best. Only experts with strong scientific backgrounds, years of extensive knowledge underpins the service we deliver.
#pharmaceutical#CDMO Find out more https://www.quaypharma.com/ pic.twitter.com/iAYDK8HMli
-
@Pfizer's#CDMO unit drives growth at hospital business https://www.outsourcing-pharma.com/Article/2020/02/03/Pfizer-s-CDMO-unit-drives-growth-at-hospital-business#.Xjk7B-4osWM.twitter … -
The 10 most-anticipated drug launches of 2020 . .
#kemwell#CDMO#CMO#biologics https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2020?mkt_tok=eyJpIjoiTlRjd01qZGpNbU15WkRndyIsInQiOiJqcUpLQm1QRnZ4dFY3NDAzRlwveis0a01ES0g3NzZ1XC9GY1N5U1wvdStvNCt2ZlBzSUQ5Tkp5ZWFMaWxHY2xqMlpzUU5maTBxSHZDaFJidHRHemQ4UVh3cDhOdDNlTVwvWEhlNjIyXC9jSXQ4WWlKQ3JjTkEyWlNCR3BIamt2YkVtMmxlSUFvMUkzTHkweWpzN1hxN3lYWkZlZz09In0%3D&mrkid=106249229 …pic.twitter.com/XqvxYiW110
-
Breaking: Catalent
$CTLT to buy Orgenesis'#celltherapy#CDMO biz Masthercell for $315m - story@BioProInsider Insider https://buff.ly/36PRRod pic.twitter.com/gdXg2Jb6nZ
-
Kemwell Vision is to be a global leader and first-choice CDMO for biologics. . .
#kemwell#CDMo#CMO#biologicspic.twitter.com/AxA1BamwvM
-
Our latest
#CDMO blog post is all about understanding reprogramming to generate iPSCs and how to get them#GMP ready. https://cdmo.ccrm.ca/blog/induced-pluripotent-stem-cells-in-cgt-understanding-reprogramming …pic.twitter.com/6GX00Ayd5e
-
This month's BPOR includes the launch of $1.1billion
#CDMO The Center for Breakthrough Medicines for#geneandcelltherapy#manufacturing#cmo#pharma#lifescienceshttps://twitter.com/PharmSource/status/1223246042705080322 …
-
New technological investments are a tangible sign of our ability to continue to focus on custom development and manufacturing (
#CDMO), at the same time enhancing the human capital of our operators in terms of dedication and know-how. http://bit.ly/Indena_CDMO pic.twitter.com/V5yQGLVQi2
Prikaži ovu nit -
Coripharma and Midas to cooperate on sales & marketing for pharmaceutical contract manufacturing of finished dosage forms.
#pharma#cmo#cdmo https://www.coripharma.is/news/coripharma-and-midas-to-cooperate-on-sales-marketing/ …pic.twitter.com/T6qidmgHNa
-
To optimize workflow of customer projects, we align our development service laboratory portfolio under one roof. Further expansion of laboratory space will continue throughout 2020.
#cdmo#investinfuture#customerbenefit https://bit.ly/36FhBDy pic.twitter.com/ZS6PM4ctUl
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
We analyze
Contract service agreements
M&A
Small and large molecule
Facility inspections